Spinal Cord Injuries (SCI)MFR20MWRNCT07711015
Myofascial Release and 20-m Speed in Wheelchair Rugby Athletes With Spinal Cord Injury
A study testing Myofascial Release in people with Spinal Cord Injuries (SCI), run by Centro Universitário Augusto Motta at 1 site in Brazil.
Trial summary
This study aims to investigate the effect of myofascial release on sprint performance in wheelchair rugby athletes with spinal cord injury. Participants will complete a 20-meter sprint test on two different days in a randomized crossover design: one day without myofascial release and one day immediately after the… Read more about this study
- Who is it for?
- Ages 18 to 18 years
- Conditions the study is for
- Spinal Cord Injuries (SCI)
- What is being tested?
- Myofascial Release
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 12 participants
- Where
- 1 siteBrazil
- Study dates
- 17 Aug 2026to 27 Sep 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 18 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Men and women
- Aged 18 years or older
- Cervical spinal cord injury (tetraplegia)
- Practice of wheelchair rugby for at leastm12 months
- Participating in team training sessions for at least 3 months prior to the study.
Who cannot join
- Musculoskeletal pain
- Injury that prevents completion of the study protocol.
- Wounds, pressure ulcers, or skin lesions at the site of myofascial release application
- Recreational athletes
- Medical contraindication to manual therapy
- Infection, fever, or acute illness at the time of assessment
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Brazil1 site
Centro Universitário Augusto Motta
Rio de Janeiro, Rio de Janeiro, 21032-060
Patricia Santos Vigário, PhD, 55 21 99813 1707, patriciavigario@souunisuam.com.br
About this study
Official title: Effect of Myofascial Release on Performance in the 20-Meter Speed Test in Wheelchair Rugby Athletes With Spinal Cord Injury
This study aims to investigate the effect of myofascial release on sprint performance in wheelchair rugby athletes with spinal cord injury.
Participants will complete a 20-meter sprint test on two different days in a randomized crossover design: one day without myofascial release and one day immediately after the intervention.
The myofascial release will be applied to the upper limb muscles involved in wheelchair propulsion using a handheld device for 90 seconds per muscle group.
Sprint performance will be measured by the time required to complete the 20-meter distance.
The study will compare performance between conditions to determine whether myofascial release improves speed.
- Conditions
- Spinal Cord Injuries (SCI)
- Being tested
- Myofascial Release
- Keywords
- Rehabilitation, Myofascial Release Therapy, Para-Athletes, Athletic Performance
- Medical subject headings
- Spinal Cord Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Myofascial ReleaseOther
Manual myofascial release will be applied to the upper limb muscles involved in wheelchair propulsion, including the biceps brachii, brachialis, and triceps muscles. The intervention will be performed by a trained physiotherapist using a handheld device, with 90 seconds of application per muscle group. The treatment will be administered immediately prior to the 20-meter wheelchair sprint test
| Study group | Role | What they receive |
|---|---|---|
| Myofascial Release | Experimental | Participants will perform a myofascial release session immediately before performing the 20-m wheelchair sprint test. Receives: Other: Myofascial Release |
| Control | No intervention | Participants will perform the 20-m wheelchair sprint test without receiving myofascial release or any other intervention. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Sprint Time (20 meters wheelchair test)
The 20-m sprint course will be marked on a flat, obstacle-free surface at the same indoor facility where the athletes regularly train, under controlled environmental conditions (wind-free environment and ambient temperature of approximately 26°C). Sprint time (s) will be measured using an electronic timing system consisting of three infrared photocell gates, positioned at the starting line, the 10-m mark, and the finish line. Participants will be instructed to complete the 20-m distance as fast as possible. The test will begin from a stationary position, with the front wheels of the wheelchair positioned immediately behind the starting line. Two trials will be performed, separated by a three-minute passive recovery period. The fastest time recorded across the two trials will be used for statistical analysis.
Measured: Immediately after each experimental condition (with and without myofascial release), during the 20-meter sprint test sessions.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Jul 2026
- Study start17 Aug 2026 (estimated)
- Primary completion27 Sep 2026 (estimated)
- Study completion27 Sep 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Spinal Cord Injuries (SCI)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- Randomized crossover design with two conditions (myofascial release and no intervention). The order of conditions is randomized, with a 48-hour washout period between sessions. Each participant acts as their own control.
- Masking
- None (open label)
- Enrolment
- 12 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centro Universitário Augusto Motta
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07711015
- Sponsor's protocol ID
- 96879526.6.0000.5235
- Acronym
- MFR20MWR
- Status last verified
- Jul 2026
- First submitted
- 8 Jun 2026
- Last updated
- 17 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Myofascial Release on Performance in the 20-Meter Speed Test in Wheelchair Rugby Athletes With Spinal Cord Injury
- ClinicalTrials.gov ID
- NCT07711015
- Acronym / sponsor ID
- MFR20MWR / 96879526.6.0000.5235
- Conditions
- Spinal Cord Injuries (SCI)
- Keywords
- Rehabilitation, Myofascial Release Therapy, Para-Athletes, Athletic Performance
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 12 participants (estimated)
- Lead sponsor
- Centro Universitário Augusto MottaUniversity, hospital or other
- Study start
- 17 Aug 2026 (estimated)
- Primary completion
- 27 Sep 2026 (estimated)
- Study completion
- 27 Sep 2026 (estimated)
- First posted
- 17 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to investigate the effect of myofascial release on sprint performance in wheelchair rugby athletes with spinal cord injury.
Participants will complete a 20-meter sprint test on two different days in a randomized crossover design: one day without myofascial release and one day immediately after the intervention.
The myofascial release will be applied to the upper limb muscles involved in wheelchair propulsion using a handheld device for 90 seconds per muscle group.
Sprint performance will be measured by the time required to complete the 20-meter distance.
The study will compare performance between conditions to determine whether myofascial release improves speed.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Randomized crossover design with two conditions (myofascial release and no intervention). The order of conditions is randomized, with a 48-hour washout period between sessions. Each participant acts as their own control.
| Arm | Type | Receives |
|---|---|---|
| Myofascial Release | Experimental | Other: Myofascial ReleaseParticipants will perform a myofascial release session immediately before performing the 20-m wheelchair sprint test. |
| Control | No intervention | –Participants will perform the 20-m wheelchair sprint test without receiving myofascial release or any other intervention. |
Who may qualify
- Ages
- 18 to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (5 listed)
- Men and women
- Aged 18 years or older
- Cervical spinal cord injury (tetraplegia)
- Practice of wheelchair rugby for at leastm12 months
- Participating in team training sessions for at least 3 months prior to the study.
Key exclusion criteria (6 listed)
- Musculoskeletal pain
- Injury that prevents completion of the study protocol.
- Wounds, pressure ulcers, or skin lesions at the site of myofascial release application
- Recreational athletes
- Medical contraindication to manual therapy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Myofascial ReleaseManual myofascial release will be applied to the upper limb muscles involved in wheelchair propulsion, including the biceps brachii, brachialis, and triceps muscles. The intervention will be performed by a trained physiotherapist using a handheld device, with 90 seconds of application per muscle group. The treatment will be administered immediately prior to the 20-meter wheelchair sprint test | Other | Myofascial Release |
Primary outcome
Sprint Time (20 meters wheelchair test)
Time frame: Immediately after each experimental condition (with and without myofascial release), during the 20-meter sprint test sessions.
The 20-m sprint course will be marked on a flat, obstacle-free surface at the same indoor facility where the athletes regularly train, under controlled environmental conditions (wind-free environment and ambient temperature of approximately 26°C). Sprint time (s) will be measured using an electronic timing system consisting of three infrared photocell gates, positioned at the starting line, the 10-m mark, and the finish line. Participants will be instructed to complete the 20-m distance as fast as possible. The test will begin from a stationary position, with the front wheels of the wheelchair positioned immediately behind the starting line. Two trials will be performed, separated by a three-minute passive recovery period. The fastest time recorded across the two trials will be used for statistical analysis.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jul 2026.
Related trials for Spinal Cord Injuries (SCI)
Recruiting
MyHand-SCI: An Active Hand Orthosis for Spinal Cord Injury
Spinal Cord Injuries, Tetraplegia
Recruiting
Transcutaneous Spinal Cord Stimulation Combined With 4-Aminopyridine and Intensive Rehabilitation in SCI
Spinal Cord Injuries
Enrolling by invitation
Brief Prolonged Exposure Therapy Versus Clinical Standard to Reduce Posttraumatic Stress Post Spinal Cord Injury
Spinal Cord Injuries, PTSD
RecruitingPhase 2/3
Pilot Study of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
Spinal Cord Injury, Traumatic Spinal Cord Injury
Active, not recruitingObservational study
SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI
Spinal Cord Injuries, Traumatic Spinal Cord Injury
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Centro Universitário Augusto Motta
Rio de Janeiro, Brazil
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Myofascial Release in people with Spinal Cord Injuries (SCI), run by Centro Universitário Augusto Motta at 1 site in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Sprint Time (20 meters wheelchair test) (time frame: Immediately after each experimental condition (with and without myofascial release), during the 20-meter sprint test sessions.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026.